SCHEMBL13779247

SCHEMBL13779247

Cc1cccc(N/N=C/c2cccnc2)c1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.72
▸ RAB9A P51151 7/20 0.72
▸ GAA P10253 7/20 0.72
▸ ALDH1A1 P00352 9/20 0.70
▸ SMN1; SMN2 Q16637 8/20 0.70
▸ MAPT P10636 7/20 0.70
▸ LMNA P02545 4/20 0.70
▸ GFER P55789 2/20 0.59
▸ TDP1 Q9NUW8 2/20 0.59
▸ KMT2A Q03164 4/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ NPSR1 Q6W5P4 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ HSP90AA1 P07900 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.53
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ HPGD P15428 1/20 0.51
▸ POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9442365 0.82 RAB9A (0.74) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL9442364 0.82 RAB9A (0.74) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL11486327 0.82 ALDH1A1 (0.74) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL11226669 0.82 ALDH1A1 (0.74) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL9173819 0.79 ABL1 (0.47) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL28255841 0.79 GFER (0.65) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL2790144 0.77 RAB9A (0.52) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL19034090 0.75 NOX1 (0.67) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL11674750 0.75 NOX1 (0.67) NPC1RAB9AGAAALDH1A1SMN1; SMN2
SCHEMBL11674747 0.75 NOX1 (0.67) NPC1RAB9AGAAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction FORSCHUNGSVERBUND BERLIN E.V. (DE) 2009-07-09 — — US disclosed
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction FORSCHUNGSVERBUND BERLIN E.V. (DE) 2009-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction PRKCH, AIP, PRKCE NPC1 1716/4885RAB9A 959/4885GAA 941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback